Details

Autor(en) / Beteiligte

• Scholten, Lianne
• Klompmaker, Sjors
• Van Hilst, Jony
• Annecchiarico, Mario M
• Balzano, Gianpaolo
• Casadei, Riccardo
• Fabre, Jean-Michel
• Falconi, Massimo
• Ferrari, Giovanni
• Kerem, Mustafa
• Khatkov, Igor E
• Lombardo, Carlo
• Manzoni, Alberto
• Mazzola, Michele
• Napoli, Niccolò
• Rosso, Edoardo E
• Tyutyunnik, Pavel
• Wellner, Ulrich F
• Fuks, David
• Burdio, Fernando
• Keck, Tobias
• Hilal, Mohammed Abu
• Besselink, Marc G
• Boggi, Ugo

Titel

Outcomes After Minimally Invasive Versus Open Total Pancreatectomy: A Pan-European Propensity Score Matched Study

Ist Teil von

• Annals of surgery, 2023-02, Vol.277 (2), p.313

Ort / Verlag

United States

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• To assess postoperative 90-day outcomes after minimally invasive (laparoscopic/robot-assisted) total pancreatectomy (MITP) in selected patients versus open total pancreatectomy (OTP) among European centers. Minimally invasive pancreatic surgery is becoming increasingly popular but data on MITP are scarce and multicenter studies comparing outcomes versus OTP are lacking. It therefore remains unclear if MITP is a valid alternative. Multicenter retrospective propensity-score matched study including consecutive adult patients undergoing MITP or OTP for all indications at 16 European centers in 7 countries (2008-2017). Patients after MITP were matched (1:1, caliper 0.02) to OTP controls. Missing data were imputed. The primary outcome was 90-day major morbidity (Clavien-Dindo ≥3a). Secondary outcomes included 90-day mortality, length of hospital stay, and survival. Of 361 patients (99MITP/262 OTP), 70 MITP procedures (50 laparoscopic, 15 robotic, 5 hybrid) could be matched to 70 OTP controls. After matching, MITP was associated with a lower rate of major morbidity (17% MITP vs. 31% OTP, P = 0.022). The 90-day mortality (1.4% MITP vs. 7.1% OTP, P = 0.209) and median hospital stay (17 [IQR 11-24] MITP vs. 12 [10-23] days OTP, P = 0.876) did not differ significantly. Among 81 patients with PDAC, overall survival was 3.7 (IQR 1.7-N/A) versus 0.9 (IQR 0.5-N/ A) years, for MITP versus OTP, which was nonsignificant after stratification by T-stage. This international propensity score matched study showed that MITP may be a valuable alternative to OTP in selected patients, given the associated lower rate of major morbidity.